Zobrazeno 1 - 10
of 286
pro vyhledávání: '"Yoshinosuke Fukuchi"'
Publikováno v:
Allergology International, Vol 61, Iss 2, Pp 219-229 (2012)
Tulobuterol patch (Hokunalin™ Tape), which contains a β2-adrenergic agonist, is the first bronchodilator to be available as a transdermal patch. This drug delivery system ensures that the time at which the peak drug concentration in the blood is r
Externí odkaz:
https://doaj.org/article/2e26ceaa899848da8fa2d7b137950de6
Autor:
Motokazu Kato, Hironi Makita, Koji Uemura, Yoshinosuke Fukuchi, Motoi Hosoe, Charlotte Emery, Mark Higgins, Benjamin Kramer
Publikováno v:
Allergology International, Vol 59, Iss 3, Pp 285-293 (2010)
ABSTRACT: Background: Indacaterol is an investigational, novel, inhaled once-daily ultra-long-acting beta-2 agonist for the treatment of chronic obstructive pulmonary disease (COPD). This study evaluated the 24-h bronchodilatory efficacy and safety o
Externí odkaz:
https://doaj.org/article/0d59abd2b50d43d1ab1860e26cd5dc71
Publikováno v:
Lung Diseases and Cancer ISBN: 9781849841542
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::085508dd7cda3e18fceb308e81ba7910
https://doi.org/10.1183/2312508x.10018321
https://doi.org/10.1183/2312508x.10018321
Autor:
Kazuhisa Takahashi, Satomi Shiota, Yasuhiro Yamaguchi, Takahide Nagase, Yoshinosuke Fukuchi, Kozui Kida, Yuzo Kodama, Masaki Ishii, Yuji Kusunoki, Masahiro Akishita, Hironobu Hamaya
Publikováno v:
Sleep and Breathing. 23:1095-1100
In patients with overlap syndrome (OVS), the pathophysiologies of obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease can interact with one another. Focusing on low arousal threshold, the authors evaluated polysomnographic feature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1944a916fc4969e7fb37a1d851c9739
https://doi.org/10.1007/s11325-019-01786-7
https://doi.org/10.1007/s11325-019-01786-7
Autor:
Kenichi Ohara, Yoshinosuke Fukuchi, Kazuto Hirata, Masaharu Nishimura, Ataru Igarashi, Hajime Yoshisue, Jean Bernard Gruenberger, Atsushi Nagai, Masakazu Ichinose
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Ataru Igarashi,1 Yoshinosuke Fukuchi,2 Kazuto Hirata,3 Masakazu Ichinose,4 Atsushi Nagai,5 Masaharu Nishimura,6 Hajime Yoshisue,7 Kenichi Ohara,8 Jean-Bernard Gruenberger9 1Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1b554bd386389040d85df6707a9150a
https://doi.org/10.2147/copd.s167476
https://doi.org/10.2147/copd.s167476
Autor:
Aki Mitsui, Naoko Shimada, Kazuhisa Takahashi, Naoko Arano, Hario Baskoro, Kuniaki Seyama, Keiko Karasutani, Yohei Suzuki, Tadashi Sato, Yuzo Kodama, Yoshinosuke Fukuchi
Publikováno v:
Journal of Visualized Experiments.
Emphysema is a significant feature of chronic obstructive pulmonary disease (COPD). Studies involving an emphysematous mouse model require optimal lung fixation to produce reliable histological specimens of the lung. Due to the nature of the lung's s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57eb52ef6354d1b73c9ce4ab122def59
https://doi.org/10.3791/58197-v
https://doi.org/10.3791/58197-v
Autor:
Yunchao Huang, Haiquan Chen, Qunyou Tan, Jie He, Yoshinosuke Fukuchi, Mahmoud Ismail, Xiangning Fu, Zhijun Han, Jianhua Fu, Qinghua Zhou, Wentao Fang, Zhongmin Jiang, Deruo Liu, Alessandro Brunelli, Lanjun Zhang, Ti Tong, Andrea Imperatori, Javier Aragón Valverde, Mohsen Ibrahim, Lin Xu, Jin-Shing Chen, Qun Wang, Tiansheng Yan, Shanqing Li, Yin Li, Lijie Tan, Xiaofei Li, Weimin Mao, Calvin S.H. Ng, Shugeng Gao, Shidong Xu, Chun Chen, Jianxing He, Xun Zhang, Hui Li, Xingyi Zhang, Danqing Li, Xiuyi Zhi, Zhentao Yu, René Horsleben Petersen, Nuria M. Novoa, Yongyu Liu, Lunxu Liu, Gening Jiang, Carlos Rodriguez-Lucas, Zhu Zhang
Publikováno v:
Journal of thoracic disease. 10(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b621ef3dfef80c2118914b4ecd0d00
https://pubmed.ncbi.nlm.nih.gov/30622808
https://pubmed.ncbi.nlm.nih.gov/30622808
Autor:
Toshihisa Arai, Hiroyuki Ohbayashi, Kai Shibata, Yasuhiro Setoguchi, Yoshinosuke Fukuchi, Yukinori Sakata
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 37:73-80
Background Mucolytic agents are often used in Japan to ease excessive mucus production in patients with chronic obstructive pulmonary disease (COPD) or bronchial asthma (BA); the treatment ameliorates dyspnea and improves quality of life (QOL). Aim E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fce59161a7971a144a4d903a33fee55
https://doi.org/10.1016/j.pupt.2016.03.001
https://doi.org/10.1016/j.pupt.2016.03.001
Autor:
Kai Shibata, Hiromasa Inoue, Masakazu Ichinose, Hideaki Miyagishi, Koichiro Tatsumi, Yoshinosuke Fukuchi, Yukinori Sakata, Yasuhiro Marukawa
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Yoshinosuke Fukuchi,1 Koichiro Tatsumi,2 Hiromasa Inoue,3 Yukinori Sakata,4 Kai Shibata,4 Hideaki Miyagishi,4 Yasuhiro Marukawa,4 Masakazu Ichinose5 1Department of Respiratory Medicine, Graduate School of Medicine, Juntendo University, Tokyo, 2Depart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6ba789d188c1270368c2a0d5c5a9dbb
http://europepmc.org/articles/PMC4846053
http://europepmc.org/articles/PMC4846053
Autor:
Satomi Shiota, Yoshiteru Morio, Shin-ichiro Iwakami, Liu Zuoyou, Yoshinosuke Fukuchi, Kazuhisa Takahashi, Ai Sugiyama, Hiroki Ienaga, Mitsuaki Sekiya
Publikováno v:
Respiratory physiologyneurobiology. 262
Pulmonary hypertension (PH) due to lung diseases is classified as group 3 by the Dana Point classification. Given the basic pathophysiological conditions of group 3 lung diseases and the previously well-known concept of hypercapnic pulmonary vasocons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a59ec9eced3354f4b48c85648f8d3878
https://pubmed.ncbi.nlm.nih.gov/30660859
https://pubmed.ncbi.nlm.nih.gov/30660859